Abingdon Health Ltd (“Abingdon” or “the Company”), a specialist medical diagnostics company, is pleased to announce the appointment of Richard Marlow as Finance Director.
Prior to joining Abingdon , Richard Marlow spent 16 years at leading business advisory firm, Deloitte. For the last 12 years he was part of the Corporate Finance, Transaction Services team where he advised on over 75 transactions, including acquisitions, disposals, public offers and other investment circular work, including a large number of IPOs and rights issues for companies on the Main and AIM markets.
Chris Hand, CEO of Abingdon Health, said: “Richard brings first rate accounting and business skills to the Company. His appointment represents a further strengthening of the senior team as we continue to progress our strategy of creating a commercially-focussed medical diagnostics business. There is a growing global need for better and faster diagnostic tests. With the capabilities to develop, manufacture and sell, Abingdon is well placed to bring the next generation of innovative, medical diagnostic products to the market.”